Author:
Baum Ellen Z,Wagaman Pamela C,Ly Linh,Turchi Ignatius,Le Jianhua,Bucher Doris,Bush Karen
Reference42 articles.
1. BCX-1812 (RWJ-270201): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design
2. Bantia, S., Ananth, S., Horn, L., Parker, C., Gulati, U., Chand, P., Babu, Y. and Air, G., 2000. Antivir. Res. 46 (Abstract 82).
3. Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir
4. In Vitro Selection and Characterisation of Influenza B/Beijing/1/87 Isolates with Altered Susceptibility to Zanamivir
5. Zanamivir Susceptibility Monitoring and Characterization of Influenza Virus Clinical Isolates Obtained during Phase II Clinical Efficacy Studies
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献